04.06.2020 | Original Article | Ausgabe 1/2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate
Kathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, Rémi Tod, Jérôme Massardier, Jean-Pierre Lotz, Touria Hajri, Olivier Colomban, Michael J. Seckl, Ray Osborne, Gilles Freyer, François Golfier, Benoit You
09.06.2020 | Original Article | Ausgabe 1/2020
YLZ-F5, a novel polo-like kinase 4 inhibitor, inhibits human ovarian cancer cell growth by inducing apoptosis and mitotic defects
Yongxia Zhu, Zhihao Liu, Yanling Qu, Jun Zeng, Meiqin Yang, Xiaoyi Li, Zhaodi Wang, Junxiang Su, Xueqin Wang, Luoting Yu, Yue Wang
11.06.2020 | Original Article | Ausgabe 1/2020
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine
Xandra García-González, Bartosz Kaczmarczyk, Judith Abarca-Zabalía, Fabienne Thomas, Pilar García-Alfonso, Luis Robles, Vanessa Pachón, Ángeles Vaz, Sara Salvador-Martín, María Sanjurjo-Sáez, Luis A. López-Fernández
12.06.2020 | Original Article | Ausgabe 1/2020
Open Access
Influences of preoperative metformin on immunological factors in early breast cancer
Takahiro Tsukioki, Tadahiko Shien, Takehiro Tanaka, Yoko Suzuki, Yukiko Kajihara, Minami Hatono, Kengo Kawada, Mariko Kochi, Takayuki Iwamoto, Hirokuni Ikeda, Naruto Taira, Hiroyoshi Doihara, Shinichi Toyooka
14.06.2020 | Original Article | Ausgabe 1/2020
C-reactive protein at 1 month after treatment of nivolumab as a predictive marker of efficacy in advanced renal cell carcinoma
Go Noguchi, Noboru Nakaigawa, Susumu Umemoto, Kota Kobayashi, Yosuke Shibata, Sohgo Tsutsumi, Masato Yasui, Shinji Ohtake, Takahisa Suzuki, Kimito Osaka, Kentaro Muraoka, Hisashi Hasumi, Keiichi Kondo, Yuka Igarashi, Tetsuro Sasada, Takeshi Kishida, Masahiro Yao
16.06.2020 | Original Article | Ausgabe 1/2020
Open Access
Effect of food on the pharmacokinetics of the WEE1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors
Mats Någård, Mei-Lin Ah-See, Karen So, Marit Vermunt, Fiona Thistlethwaite, Mariette Labots, Patricia Roxburgh, Alain Ravaud, Mario Campone, Liselot Valkenburg-van Iersel, Lone Ottesen, Yan Li, Ganesh Mugundu
20.06.2020 | Original Article | Ausgabe 1/2020
A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)
Shin-ichi Fukumoto, Satoshi Oizumi, Masao Harada, Noriaki Sukoh, Kosuke Nakano, Satoshi Fuke, Jun Sakakibara-Konishi, Kei Takamura, Kenichiro Ito, Yuka Fujita, Yutaka Nishigaki, Toshiyuki Harada, Kenji Akie, Ichiro Kinoshita, Toraji Amano, Hiroshi Isobe, Hirotoshi Dosaka-Akita, Masaharu Nishimura, the Hokkaido Lung Cancer Clinical Study Group
25.06.2020 | Original Article | Ausgabe 1/2020
Sorafenib exposure and its correlation with response and safety in advanced hepatocellular carcinoma: results from an observational retrospective study
Satoshi Noda, Daiki Hira, Rie Osaki, Takehide Fujimoto, Hiroya Iida, Sachiko Tanaka-Mizuno, Akira Andoh, Masaji Tani, Yoshito Ikeda, Shin-ya Morita, Tomohiro Terada
27.06.2020 | Original Article | Ausgabe 1/2020
Open Access
Wide variation in tissue, systemic, and drain fluid exposure after oxaliplatin-based HIPEC: results of the GUTOX study
Loek A. W. de Jong, Fortuné M. K. Elekonawo, Marie Lambert, Jan Marie de Gooyer, Henk M. W. Verheul, David M. Burger, Johannes H. W. de Wilt, Etienne Chatelut, Rob ter Heine, Philip R. de Reuver, Andre J. A. Bremers, Nielka P. van Erp
